Early Detection, Better Outcomes: Screening for CKM Syndrome in Practice
PA Le walks through screening recommendations for CKM across the lifespan, highlighting tools and timelines from the AHA and ADA. He breaks down practical approaches to identifying CKD, metabolic syndrome, and cardiovascular risk using labs, imaging, and risk calculators. Viewers will learn how to interpret the KDIGO heat map and use tools like UACR and eGFR to stage risk and guide decision-making. The video reinforces the powerful role PAs play in early detection and long-term prevention.
Key Takeaways:
- Risk factors for CVD develop across the lifespan and require regular screening.
- CKD can progress silently until late stages.
- UACR is a tool that can help with earlier detection of CKD and is used in staging.
Speaker
Click on the photo below to learn more about the speaker.
References and Additional Resources:
Cardiovascular Kidney Metabolic Health: A Presidential Advisory From the AHA. Heart.org. Accessed July 28, 2025. https://professional.heart.org/en/science-news/cardiovascular-kidney-metabolic-health-a-presidential-advisory
Eknoyan G, Lameire N, Eckardt K, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:5-14.
Khan MS, Shahid I, Anker SD, et al. Albuminuria and heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81(3):270-282. doi:10.1016/j.jacc.2022.10.028
Kidney failure risk factor: Urine albumin-creatinine ratio (uACR). National Kidney Foundation. Accessed July 29, 2025. https://www.kidney.org/kidney-failure-risk-factor-urine-albumin-creatinine-ratio-uacr
Supported by
